The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Mer­ck signs MoU with In­di­an CD­MO; Scor­pius de­lays pub­lic of­fer­ing

8 months ago

Evotec to cut 400 work­ers and close sites, cit­ing ‘no new sig­nals of re­cov­ery’ this year

8 months ago
Pharma

Ex­clu­sive: Gates Foun­da­tion backs start­up us­ing op­to­ge­net­ics to man­u­fac­ture bi­o­log­ics

9 months ago
Financing
R&D

Pres­sure from an­ti-Chi­na leg­is­la­tion be­gins to rip­ple through bio­phar­ma

9 months ago
China
Pharma

Leg­end con­tin­ues Carvyk­ti fac­to­ry builds to ce­ment CAR-T ter­ri­to­ry with J&J

9 months ago
Pharma
Cell/Gene Tx

Cor­rect­ed: No­vo Nordisk to file in EU and Chi­na with late-phase in­sulin plus semaglu­tide da­ta – but not yet in the US

9 months ago
R&D
FDA+

No­vavax plots to re­duce Eu­ro­pean foot­print to be­come a ‘lean­er’ com­pa­ny

9 months ago
Pharma

Lil­ly con­tributes to iso­tope sup­pli­er fundraise; Lay­offs at Aji­nomo­to   

9 months ago

WuXi Bio gains some trac­tion in Eu­rope in the face of Biose­cure threat in the US

9 months ago
China

Lil­ly crush­es ex­pec­ta­tions with GLP-1 fran­chise, as sup­ply con­straints ease

9 months ago
Pharma

Big drug­mak­ers have cut out­side R&D spend­ing amid broad pull­back, key con­trac­tor warns

9 months ago
Pharma

Pfiz­er in­vests $98M in Aus­tralian man­u­fac­tur­ing to help de­vel­op new an­timi­cro­bial treat­ments

9 months ago

No­vo Nordisk dou­bles US We­govy pre­scrip­tions as short­ages start to ease, but earn­ings fall be­low ex­pec­ta­tions 

9 months ago
Pharma

Hims takes steps to lock up drug sup­ply for its boom­ing weight loss busi­ness

9 months ago
Pharma
Health Tech

Dos­es of Lil­ly's block­buster GLP-1 in short­age have been pulled from FDA sup­ply list

9 months ago
Pharma
FDA+

Ky­owa Kirin di­vests Chi­na unit, prunes dis­cov­ery and man­u­fac­tur­ing work

9 months ago
Pharma

Pfiz­er mulls fa­cil­i­ty sale; GSK pe­nal­ized in South Ko­rea for ad­min­is­tra­tive breach

9 months ago

Sanofi pours €1.3B in­to new in­sulin man­u­fac­tur­ing plant in Frank­furt

9 months ago

Sanofi sues Sarep­ta, al­leg­ing that Duchenne treat­ment Ele­v­idys in­fringes on AAV patents

9 months ago
Law

Umo­ja to dose first pa­tient with in vi­vo CAR-T by end of this year

9 months ago
R&D
Cell/Gene Tx

Pfiz­er ups 2024 guid­ance by $1B af­ter mul­ti­ple rounds of cost cuts

9 months ago
Pharma

Pfiz­er cuts 210 North Car­oli­na work­ers af­ter it of­fi­cial­ly dis­con­tin­ues failed Duchenne gene ther­a­py

9 months ago
People
Cell/Gene Tx

WuXi AppTec sees US rev­enue de­cline amid Biose­cure threat

9 months ago
China

Up­dat­ed: Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al

9 months ago
R&D
Pharma
First page Previous page 891011121314 Next page Last page
A service from the Financial Times